226P Prevalence and Characteristics of HR+/HER2- MBC with ESR1 Mutations Post-Cdk Inhibitor Therapy
R. Scafetta,K. Venetis, G. Cursano,S. Gandini,P.P.M. Berton Giachetti, E. Mane,C. De Angelis,F. Pepe,U. Malapelle,S. Scagnoli,A. Botticelli,A. Marra, S.M. Rossi, R. Troiano, E. Speziale, G. Perrone,E. Guerini Rocco,G. Curigliano,C. Criscitiello,N. Fusco ESMO Open（2024）
AI 理解论文
溯源树
样例
